SHENYANG, China, March 3, 2019 /PRNewswire/ -- 3SBio Inc. ("3SBio") (HKEX: 1530) and Taiwan Liposome Company, Ltd. ("TLC") (Nasdaq: TLC, TWO: 4152) today announced an exclusive partnership to commercialize in
Growth Capitalist (https://growthcapitalist.com/2019/03/3sbio-and-tlc-form-exclusive-partnership-to-commercialize-two-nanox-products-in-mainland-china/)
SHENYANG, China, March 3, 2019 /PRNewswire/ -- 3SBio Inc. ("3SBio") (HKEX: 1530) and Taiwan Liposome Company, Ltd. ("TLC") (Nasdaq: TLC, TWO: 4152) today announced an exclusive partnership to commercialize in